عرض الرسائل ذات التصنيف HRS-AKIعرض الكل
Terlipressin
Assess TERLIpressin for Hepatorenal Syndrome
As a clinical pharmacist, you should evaluate the use of terlipressin for hepatorenal syndrome. Terlipressin ( Glypressin, Haemoxamine ) will be the first FDA-approved medication for hepatorenal syndrome with acute kidney injury (HRS-AKI). HRS-AKI typically occurs in patients with cirrhosis and ascites who develop splanchnic vasodilation. This causes decreased perf…
قراءة المزيد
Terlipressin
Pharmacotherapy of cirrhosis
Overview ㅡ Cirrhosis is defined as diffuse injury to liver characterized by destruction of hepatocytes and their replacement by fibrous tissue. Typically, the disease develops slowly over months or years. Early on, there are often no symptoms. As the disease worsens, a person may become tired, weak, itchy, have swelling in the lower legs, develop yellow skin (elevat…
قراءة المزيد
Social Plugin